Renjie Zhang

Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT

F. Zhou, Kaiyu Qian, Xinghuan Wang, 2020, Cancer Cell International.

A randomized, crossover, phase I clinical study to evaluate bioequivalence and safety of tofacitinib and Xeljanz® in Chinese healthy subjects.

Yicheng Zhao, Xin-Ning Qu, Jing Lan, 2022, International immunopharmacology.

MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3

G. Wang, Kaiyu Qian, Xinghuan Wang, 2022, Oncogene.

Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT

Kaiyu Qian, Xinghuan Wang, Yu Xiao, 2020, Cancer cell international.

MALDI-MS-based biomarker analysis of extracellular vesicles from human lung carcinoma cells

Hui Yang, Chao Zhao, Zitong Yu, 2021, RSC advances.

Identification of Chemotherapeutic Dihydromyricetin With Enhanced Anti-tumor Activity and Biosafety for Muscle Invasive Bladder Cancer

Xinghuan Wang, Zijian Wang, Renjie Zhang, 2021 .

The Role of COL22A1 in the Pathophysiology of Hepatocellular Carcinoma: Evidence from Bioinformatics Exploration

Jialin Liu, Yuanyuan Chen, Renjie Zhang, 2022, Cancer Management and Research.